Revised
Hepatitis C virus (HCV) infection is a serious bloodborne chronic disease that damages liver cells and can lead to severe liver diseases such as cirrhosis (scaring of the liver), liver cancer or liver failure.
Hepatitis C virus (HCV) infection is a serious bloodborne chronic disease that damages liver cells and can lead to severe liver diseases such as cirrhosis (scaring of the liver), liver cancer or liver failure.
Chronic Hepatitis C Infection in the United States
Let’s review some approximate hepatitis C numbers and remember that all numbers used are best estimates.
- In the United States, 4 million people (1.3% of 307 million) are chronically infected with hepatitis C virus. This includes the higher HCV populations of people in prison, Viet Nam veterans, and people co-infected with HIV.
- Of these people, 2.5 million are unaware they have the virus, leaving 1.5 million people who know they have chronic hepatitis C.
- New cases add 15,000 each year. People successful treated reduce 35,000 each year. (Perhaps 500,000 people have been treated the past 9 years at 40% success rate.)
Plan A – Treatment for Hepatitis C
Plan A treatment for chronic hepatitis C infection is the current anti-viral treatment (“standard of care”) consisting of pegylated interferon injections in combination with ribavirin pills.
- Treatment is either 24 or 48 weeks (depending on success and genotype) and success rate is about 50% measured as sustained virological response (SVR), defined as the absence of HCV virus in the blood 24 weeks following discontinuation of treatment.
- There are physical and psychological side effects of treatment and they can continue after treatment is over. Adverse events and non-compliance result in up to 20% of people discontinuing treatment.
- Cost of medication alone (48 weeks) is over $27,000. And this does not include the cost of medical visits, lab, and medicines for side effects.
- The goal of this treatment is to eliminate the hepatitis C virus (SVR) thereby reducing the risk of serious liver problems and death from infection.
- In the future, new drugs will become part of Plan A. These drugs may reduce the length of treatment and improve success (SVR).
- Most of the medical community and many people infected with hepatitis C are generally aware of Plan A treatment.
In regard to treatment for hepatitis C: the majority of time, energy and money are being used to promote Plan A – with limited results.
For the majority of people who have chronic hepatitis C and have not cleared the virus (SVR) with Plan A, they need Plan B (explained below).
Plan B – Treatment for Hepatitis C
Plan B is simply an alternative to Plan A. It includes “alternative” or natural medicine (herbs and supplements) to treat hepatitis C. Natural medicine is becoming more widespread in the United States and is successfully used to treat chronic health problems throughout the world.
Plan B is for people chronically infected with hepatitis C and dependent on another course of action. This includes those who failed or refused current standard treatment for whatever reasons – such as financial, mental (depression/mental illness), behavioral (alcohol/drug use) or access.
The majority of people with hepatitis C need a viable alternative plan. This includes changes in lifestyle, diet, and adding natural remedies to maintain health and protect the liver. It also includes receiving reliable information from many sources.
The goal of Plan B treatment is to improve quality of life and protect the liver from serious problems. It may not eliminate the hepatitis C virus (the cause of infection).
Because there is concern among some people who have either failed or not received Plan A treatment, it is important to look at possible outcomes of HCV infection.
Possible Outcomes of Chronic Hepatitis C Infection
Our knowledge of the natural history of hepatitis C is still limited. Many people who are chronically infected have no symptoms; others develop mild to serious symptoms. HCV infection is largely silent and can remain silent for decades. However, as time goes by and people age, there is a greater likelihood for more symptoms due to liver damage.
The majority of people (60% to 85%) with chronic HCV will have no advanced liver disease (including cirrhosis) during their lifetime. Various studies estimate:
- 20% may develop cirrhosis after 20 to 30 years of infection (range 5% to 25%)
- 30% may develop cirrhosis after 30 to 50 years of infection (range 15% to 40%)
Cirrhosis is categorized as compensated (heavily scarred) or decompensated (life-threatening).
- The majority of those with compensated cirrhosis can still live full, productive lives. There is an 80% to 90% 5-year survival rate in patients with compensated cirrhosis.
- 20% of those with compensated cirrhosis may progress to decompensated cirrhosis where there is a 50% survival rate at 5 years.
Other outcomes
- Risk of hepatocellular carcinoma (liver cancer) is 1 to 5 percent (higher with people that have cirrhosis).
- In the United States, HCV is the major reason for liver transplants and causes an estimated 10,000 to 12,000 deaths annually.
It is uncertain with hepatitis C who will develop advanced liver disease. It is important to know that there are helpful alternative protocols available now to improve the odds for long-term health – see Plan B.
Plan B – Useful Herbs, Supplements, and Lifestyle Changes
Herbs and supplements can do the following: protect the liver, reduce inflammation, strengthen the immune system, reduce viral replication, and provide anti-oxidant support.
Lifestyle changes can contribute to better liver health. These include dietary changes, avoidance of alcohol and drugs, reduction of stress, and proper rest/sleep. Also, activities (such as prayer, meditation, affirmations, and ritual) can support mind-body interaction necessary for healing.
Here are examples of herbs and supplements for hepatitis C:
- Liver Protection – milk thistle, schizandra
- Reduce Inflammation – echinacea, turmeric, ginger, green tea, licorice, fish oil
- Immune Support – echinacea, astragalus, reishi and shiitake mushrooms
- Reduce Virus Replication – echinacea, garlic, licorice, olive leaf, St. Johns wort, selenium,
- Anti-Oxidant Support – turmeric, vitamins C and E, alpha lipoic acid, green tea,
- Liver Cleansing Food/Beverage – beets (with lemon and olive oil), dandelion tea
Note: These remedies are noted for informational purposes only. It is recommended that you receive advice from a medical or herbal professional regarding herbs for specific conditions.
There is little Western scientific evidence that natural remedies have anti-HCV properties or alter the immune response in a way that eliminates HCV. Yet, the health benefits of natural remedies are supported by expert opinion and a long history of use. And there is observational evidence that herbs can reduce the hepatitis C virus and slow the progression of HCV.
Plan B – Education and Information
Plan B also includes more education and reliable information from many sources about alternatives to Plan A. More information is needed about herbs and lifestyle changes. Not just Western scientific information, but also medical information from Asia and Europe.
One reason we are not hearing more about Plan B is that there is not much money to be made from inexpensive herbs. They are not part of “conventional” medicine and not supported by conventional medical education.
Conclusion and References
This blog only touches upon the need for more details of Plan B. Serious public health research and education is needed. Being healthy is our own responsibility.
Email private comments to Steven Maimes
Selected Sources for Herbs:
Additional Information
Alternative Hepatitis C Protocol (prepared by Steven Maimes)
Hepatitis C Choices (excellent free resource-book)
HCV Advocate (website with useful and important information)
Maimes Report on Hepatitis C Infection in New Hampshire (2002, PDF download)
Adaptogens: Herbs for Strength, Stamina, and Stress Relief (2007, book to order)
